Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Cyrus Harmon

Director at Olema Pharmaceuticals, Inc. (OLMA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $744K

Reported trades

Filed Stock Type Shares Price Value Since
Jul 27SEC OLMAOlema Pharmaceuticals, Inc. Sell 12,500715,270 held (−2%) $11.58 $145K -32.5%
Jul 27SEC OLMAOlema Pharmaceuticals, Inc. Sell 12,500702,770 held (−2%) $11.71 $146K -33.2%
Jan 21SEC OLMAOlema Pharmaceuticals, Inc. Sell 10,000727,770 held (−1%) $26.88 $269K -70.9%
Jan 16SEC OLMAOlema Pharmaceuticals, Inc. Sell 3,489737,770 held (−0%) $29.12 $102K -73.1%
Dec 29SEC OLMAOlema Pharmaceuticals, Inc. Sell 2,881741,259 held (−0%) $28.53 $82K -72.6%